Results 1 to 10 of about 33,936 (279)

Evolutionary History and Attenuation of Myxoma Virus on Two Continents [PDF]

PLoS Pathogens, 2012
The attenuation of myxoma virus (MYXV) following its introduction as a biological control into the European rabbit populations of Australia and Europe is the canonical study of the evolution of virulence.
Elodie Ghedin, Isabella M Cattadori, Peter J Hudson   +2 more
exaly   +7 more sources

Cardiac myxoma: A report of two cases and review of the literature [PDF]

Radiology Case Reports
Cardiac myxoma is the most common benign primary tumor of the heart, with 75%-85% of cases occurring in the left atrium. According to the etiology and genetics, cardiac myxomas are divided into sporadic cardiac myxomas and familial or syndrome-related ...
Xiang-Su Xue, MD, Jin-Yu Liang, MD, Shi-Jun Bao, MD, Hong-Feng Ma, MD, Bin Zhan, MD, Yu Liu, MD   +5 more
doaj   +2 more sources

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication [PDF]

PLoS Pathogens, 2013
Myxoma virus (MYXV)-encoded protein M029 is a member of the poxvirus E3 family of dsRNA-binding proteins that antagonize the cellular interferon signaling pathways.
Jia Liu, Stefan Rothenburg, Grant McFadden   +2 more
exaly   +3 more sources

Infected left atrial myxoma with Streptococcus gordonii: case report and literature review [PDF]

Frontiers in Oncology
Cardiac myxoma is a relatively common type of benign heart tumor, but infectious myxoma is rare. The symptoms of non-infected cardiac myxoma and infected cardiac myxoma are similar and mostly nonspecific, which can easily lead to delayed diagnosis ...
Liqin Ruan, Shixiong Chen, Jing Zhang, Guiping Peng   +3 more
doaj   +2 more sources

Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression

Signal Transduction and Targeted Therapy
Cardiac myxoma is a commonly encountered tumor within the heart that has the potential to be life-threatening. However, the cellular composition of this condition is still not well understood.
Xue-Lei, Zhijie Xu
exaly   +2 more sources

Significance of laparoscopic cytoreductive surgery for appendiceal pseudomyxoma peritonei with limited disease and low tumor burden

Asian Journal of Surgery, 2023
Objective: To investigate the clinical value of laparoscopic cytoreductive surgery (CRS) in treating of appendiceal pseudomyxoma peritonei with limited disease and low tumor burden.
Chong Wang, Xiang-Yang Yin, Lu-Biao An, Xi-Chao Zhai, Ying Cai, Guan-Jun Shi, Xi-Wen Fan, Pu Zhang, Kai-Min Wang, Rui-Qing Ma   +9 more
doaj   +1 more source

Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer

Frontiers in Oncology, 2021
ObjectiveTo describe the clinicopathological characteristics of mucinous ovarian cancer (MOC)-derived pseudomyxoma peritonei (PMP) and identify prognostic factors for survival.MethodsMedical records from patients with MOC-derived PMP who attended the ...
Fengxian Fu, Xulan Ma, Yiyan Lu, Hongbin Xu, Ruiqing Ma   +4 more
doaj   +1 more source

Cardiac Myxoma [PDF]

Autopsy and Case Reports, 2016
Primary cardiac tumors (PCT) are rare, accounting for 0.0017-0.03% in autopsy series,1,2 in contrast to metastatic tumors of the heart, which are 30 times more frequent.3,4 Nearly 75% of PCT are benign and most often represented by a myxoma in 50% of cases in the adult population.5 The World Health Organization defines a cardiac myxoma (CM) as a ...
Vera Demarchi Aiello, Fernando Peixoto Ferraz de Campos   +1 more
openaire   +3 more sources

Clinical Characteristics and Surgical Outcomes of Right Heart Myxoma and Its Comparison with Left Heart Myxoma: A Single-Center Retrospective Study

Anatolian Journal of Cardiology, 2023
Background: Cardiac myxomas are commonly located in the left atrium but rarely affect the right side of the heart. We retrospectively analyzed 28 patients receiving surgical treatment for right heart myxomas at our center and aimed to summarize the ...
Yanyi Liu, Xin Li, Zhuang Liu, Yiyao Jiang, Chenghao Lu, Shenglin Ge, Chengxin Zhang   +6 more
doaj   +1 more source

Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei

BMC Cancer, 2023
Background To investigate the expression of carcinoembryonic antigen (CEA), cancer antigen 199 (CA199) and CA125 in serum and ascites of appendiceal pseudomyxoma peritonei (PMP) patients relative to their diagnostic and predictive value.
Bing Wang, Ruiqing Ma, Benqiang Rao, Hongbin Xu   +3 more
doaj   +1 more source